• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 43
  • 42
  • 7
  • 2
  • 1
  • 1
  • Tagged with
  • 102
  • 102
  • 102
  • 19
  • 19
  • 17
  • 17
  • 17
  • 10
  • 9
  • 8
  • 7
  • 7
  • 7
  • 7
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
51

Obtenção de frações de valepotriatos através de fluido supercrítico e triagem psicofarmacológica de valeriana glechomifolia Meyer

Salles, Luisa de Andrade January 2010 (has links)
Espécies do gênero Valeriana são tradicionalmente utilizadas para tratar ansiedade, irritabilidade e desordens de sono. A Organização Mundial da Saúde indica o uso de preparações farmacêuticas como alternativa aos benzodiazepínicos para tratamento da ansiedade e insônia. Entre as substâncias ativas presentes no gênero Valeriana destacam-se os óleos voláteis, valepotriatos, flavonóides e lignanas. Entretanto, estudos farmacológicos com produtos isolados são escassos. Espécies nativas de Valeriana, que ocorrem no Rio Grande do Sul, têm sido estudadas em relação a sua composição química, sendo a espécie Valeriana glechomifolia a que possui maior teor de valepotriatos. Neste estudo, diferentes métodos de extração de valepotriatos foram comparados e extratos enriquecidos em valepotriatos foram testados em modelos animais de sedação, ansiedade e depressão. Valepotriatos isolados foram submetidos a ensaios de ligação a receptores benzodiazepínico e serotonérgico (5HT1A) e ensaios de atividade da enzima Na+K+ATPase. A extração por fluido supercrítico com dióxido de carbono (SCCO2) foi realizada em temperatura constante de 40 oC e pressões variáveis (90, 120, 150 e 200 bar) e demonstrou maior teor de valepotriatos que os métodos de extração por maceração em ultrassom e maceração Entre as diferentes pressões de extração utilizadas no método de SCCO2, o maior teor de valepotriatos foi apresentado pela fração obtida na pressão de 90 bar. Todos os extratos mostraram o mesmo perfil qualitativo de valepotriatos. Flavonóides também foram obtidos através de maceração por ultrassom em metanol. A dose letal mediana dos valepotriatos obtidos por maceração por ultrassom foi de 42±3 mg/kg, i.p. Esta mesma solução extrativa, na dose de 10 mg/kg, v.o. (gavage), foi inefetiva no labirinto em cruz elevado e tempo de sono barbitúrico, sugerindo a ausência de propriedades ansiolíticas e hipnótico-sedativas. Resultados similares foram obtidos com a solução extrativa enriquecida em flavonóides. Valtrato, acevaltrato, 1-b-acevaltrato, diavaltrato e o flavonóide codificado como B6 não apresentaram ligação ao sítio benzodiazepínico do complexo receptor GABAA, nem ao receptor serotonérgico (5HT1A) viii na faixa de concentração de 1-100 μM. Os valepotriatos inibiram a atividade da enzima Na+K+-ATPase na faixa de concentração micromolar. A fração de valepotriatos obtida por SCCO2 (10 mg/kg, gavage) foi efetiva no teste da natação forçada, sem interferir na atividade locomotora espontânea, sugerindo uma atividade do tipo antidepressiva. Em conclusão, a extração por fluido supercrítico com dióxido de carbono mostrou-se eficiente para a obtenção de frações enriquecidas em valepotriatos e estas substâncias representam uma nova classe química com atividade inibitória não seletiva da enzima Na+K+ATPase, e com atividade do tipo antidepressiva. / Species of the genus Valeriana are traditionally used to treat anxiety, irritability and sleep disorders. The World Health Organization indicates pharmaceutical preparations of V. officinalis as an alternative to benzodiazepine drugs for treating anxiety and insomnia. Volatile oil, valepotriates, flavonoids and lignan have been suggested as active substances of the Valeriana genus. However pharmacological studies on isolated compounds are scarce. Species of Valeriana native to Rio Grande do Sul have been studied regarding their chemical composition being Valeriana glechomifolia the species with highest valepotriate’ contents. In this study different methods of extraction of valepotriates from aerial parts of V. glechomifolia were compared, and valepotriate’ enriched extracts were tested in mice models of sedation, anxiety and depression. Isolated valepotriates were submitted to binding to benzodiazepine and 5HT1A receptors, and assayed for the Na+K+ATPase inhibitory activity. The extraction by supercritical carbon dioxide (SCCO2) was carried out at 40 oC under 90, 120, 150 or 200 bar affording higher valepotriates contents than maceration with dichloromethane and ultrasound. The highest valepotriates yielding was obtained with SCCO2 (40 oC , 90 bar). All extracts presented the same qualitative valepotriate’ profile. Flavonoids were also obtained from methanol extracts. The median lethal dose of valepotriates obtained by maceration was determined as 42±3 mg/kg, i.p. This valepotriate’ enriched extract (10 mg/kg, p.o., gavage) was ineffective in the elevated plus maze and barbiturate sleeping time tests suggesting that it does not present anxiolitic or hypnotic-sedative properties. Similar results were obtained with flavonoids’ enriched extract. Valtrate, acevaltrate, 1-b-acevaltrate, diavaltrate and the flavonoid named B6 did not bind to benzodiazepine site of receptor GABAA complex neither to serotonergic receptor (5HT1A) at 1-100 μM. The valepotriates inhibited the Na+K+ATPase activity at micromolar concentration range. The valepotriates fraction obtained by SCCO2 (10 mg/kg, gavage) was effective in the forced swimming test without interfering with the spontaneous locomotor activity suggesting that it presents an antidepressant-like activity. In conclusion the extraction by supercritical carbon dioxide is valuable to obtain valepotriates enriched fractions; and valepotriates seem to represent new chemical entities with no selective inhibitory activity of Na+K+ATPase, as well as with antidepressant-like activity.
52

Repercussão da desnutrição, durante a gestação, sobre o Estresse oxidativo placentário e transportadores de sódio No rim da prole de ratos adultos

Duarte Vieira Filho, Leucio 31 January 2008 (has links)
Made available in DSpace on 2014-06-12T15:49:17Z (GMT). No. of bitstreams: 2 arquivo1297_1.pdf: 413812 bytes, checksum: 6e4701ae88794deb16a40909eddd00c3 (MD5) license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2008 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / A desnutrição intra-uterina tem sido correlacionada com o desenvolvimento de doenças cardiovasculares e renais, que estão vinculadas ao balanço de Na+ alterado. No presente estudo, investigamos se a má-nutrição materna eleva o estresse oxidative placentário com impacto subseqüente nos transportadores renais de Na+ dependentes de ATP, na prole. A mánutrição materna foi induzida durante a gestação através de uma dieta multicarenciada, também denominada dieta básica regional. O estresse oxidativo foi avaliado pela mensuração de substâncias reativas ao ácido tiobarbitúrico, os quais estavam 35-40% maiores nas mães malnutridas. As bombas de sódio foram avaliadas nos ratos controle e intra-uterinamente malnutridos (MalN) (25 e 90 dias de vida). A atividade da (Na++K+)ATPase foi idêntica nos grupos aos 25 dias (~150 nmol Pi×mg-1×min-1); aumentou 40% com o desenvolvimento nos ratos controle, mas permaneceu constante na prole de mães malnutridas. Em contraste, nos ratos em idade juvenil, a atividade da Na+-ATPase foi maior nos animais MalN do que nos controles (70 vs 25 nmol Pi×mg-1×min-1). Contudo, ela não acompanhou o desenvolvimento renal e corpóreo: aos 90 dias ela era 50% menor no MalN do que no controle. A estimulação máxima da Na+-ATPase pela angiotensina II foi 35% menor no MalN do que nos ratos controle e foi deflagrada apenas com doses bem maiores do peptídeo (10-10M), quando comparadas aos animais controles (10-14M). A atividade da proteína kinase C, que é um mediadora dos efeitos da angiotensina II na Na+-ATPase, atingiu um terço do valor normal. Podemos concluir que o estresse oxidativo placentário induzido má-nutrição altera o controle fino da manipulação renal de Na+ na prole e contribui para a programação de distúrbios tardios da homeostase de Na+
53

AVALIAÇÃO DOS EFEITOS FARMACOLÓGICO E TOXICOLÓGICO DE 4- ORGANOCALCOGENO-ISOQUINOLINAS / EVALUATION OF PHARMACOLOGYC AND TOXICOLOGYC EFFECTS OF 4-ORGANOCHALCOGEN-ISOQUINOLINES

Sampaio, Tuane Bazanella 12 March 2014 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Monoamine oxidase (MAO) is a target enzyme in the treatment of several pathologies, being that new molecules which inhibit of a selective, potent and reversible manner their isoforms and without adverse effects are searched. In this way, the first manuscript of this dissertation evaluated the in vitro inhibitory potential of the 4-organochalcogen-isoquinolines on cerebral MAO-A and B activities, elucidating their kinetics profile and the interaction compound x enzyme. The results demonstrated that all compounds were selective inhibitors of MAO-B, being compound 3-phenyl-4-(selenophenyl) isoquinoline the most potent. The kinetics profile revealed a mixed and reversible inhibition of enzyme, consistent to the results of molecular docking. It is known that both organic selenium compounds and isoquinolines are linked to pro-oxidants situations, thus, it was investigated the in vitro effect of 4-organoseleno-isoquinolines on cerebral activities of the enzymes δ- aminolevulinate dehydratase (δ-ALA-D) e Na+, K+-ATPase, which have easily oxidized cysteine residues. Data demonstrated that compounds substituted with chloro, fluoro and trifluoromethyl in the aromatic ring bonded to the selenium atom of compound 3-phenyl-4-(selenophenyl) isoquinoline inhibited both sulfhydryl enzymes, which was not observed in the compound substituted with methyl and in a nonsubstituted compound. Furthermore, since the inhibition of enzymes δ-ALA-D and Na+, K+-ATPase was restored by dithiothreitol it is possible to propose the oxidation of cysteine residues by compounds. The selective and reversible inhibition of MAO-B and the low toxicological potential demonstrated by compound 3-phenyl-4- (selenophenyl) isoquinoline become this compound a candidate for more studies, which aim this enzyme as a therapeutic target. / A monoamina oxidase (MAO) é uma enzima alvo no tratamento de diversas patologias, sendo que novas moléculas que a inibam de maneira seletiva, potente, reversível, e ausente de efeitos adversos suas isoformas são procuradas. Neste sentido, o primeiro manuscrito desta dissertação avaliou o potencial inibitório dos 4- organocalcogeno-isoquinolinas na atividade cerebral da MAO-A e B in vitro, elucidando seus perfis cinéticos e a interação composto e enzima. Os resultados demonstram que todos os compostos apresentam inibição seletiva da MAO-B, sendo o composto 3-fenil-4-(selenofenil) isoquinolina o mais potente. O perfil cinético revelou inibição do tipo mista e reversível da enzima, coerente aos resultados do docking molecular. Sabe-se que tanto compostos orgânicos de selênio quanto isoquinolinas relacionam-se a situações pró-oxidantes, deste modo, investigou-se o efeito in vitro dos 4-organoseleno-isoquinolinas na atividade cerebral das enzimas δ- aminolevulinato dehidratase (δ-ALA-D) e Na+, K+-ATPase, as quais possuem resíduos de cisteína facilmente oxidáveis. Os dados demonstram que os compostos substituídos com cloro, flúor e trifluormetil no anel aromático ligado ao átomo de Se do composto 3-fenil-4-(selenofenil) isoquinolina inibem ambas as enzimas sulfidrílicas, o que não foi observado com o composto substituído com metil e com o composto não substituído. Além disso, visto que a inibição das enzimas δ-ALA-D e Na+, K+-ATPase foi revertida por ditiotreitol é possível propor o envolvimento da oxidação dos resíduos de cisteína pelos compostos. Devido à inibição seletiva e reversível da MAO-B e ao baixo potencial toxicológico demonstrado, o composto 3- fenil-4-(selenofenil) isoquinolina torna-se um candidato a mais estudos que possuam esta enzima como alvo terapêutico.
54

The Roles of the Na+/K+-ATPase, NKCC, and K+ Channels in the Regulation Local Sweating and Cutaneous Blood Flow During Exercise in Humans in vivo

Louie, Jeffrey January 2016 (has links)
Na+/K+-ATPase has been shown to regulate the sweating and cutaneous vascular responses during exercise; however, similar studies have not been conducted to assess the roles of the Na-K-2Cl cotransporter (NKCC) and K+ channels. Additionally, it remains to be determined if these mechanisms underpinning the heat loss responses differ with exercise intensity. Eleven young (24±4 years) males performed three 30-min semi-recumbent cycling bouts at low (30% VO2peak), moderate (50% VO2peak), and high (70% VO2peak) intensity exercise, respectively, each separated by 20-min recovery periods. Using intradermal microdialysis, four forearm skin sites were continuously perfused with either: 1) lactated Ringer solution (Control), 2) 6 mᴍ ouabain (Na+/K+-ATPase inhibitor), 3) 10 mᴍ bumetanide (NKCC inhibitor), or 4) 50 mᴍ BaCl2 (non-specific K+ channel inhibitor); sites at which we assessed local sweat rate (LSR) and cutaneous vascular conductance (CVC). Inhibition of Na+/K+-ATPase attenuated LSR compared to Control during the moderate and high intensity exercise bouts (both P˂0.01), whereas attenuations with NKCC and K+ channel inhibition were only apparent during the high intensity exercise bout (both P≤0.05). Na+/K+-ATPase inhibition augmented CVC during all exercise intensities (all P˂0.01), whereas CVC was greater with NKCC inhibition during the low intensity exercise only (P˂0.01) and attenuated with K+ channel inhibition during the moderate and high intensity exercise conditions (both P˂0.01). We show that Na+/K+-ATPase, NKCC and K+ channels all contribute to the regulation of sweating and cutaneous blood flow but their influence is dependent on the intensity of exercise.
55

The Potential of Modulating Na+ K+ Atpase Pumps and Katp Channels in the Development of a New Therapy to Treat Hyperkalemic Periodic Paralysis

Ammar, Tarek January 2017 (has links)
Hyperkalemic periodic paralysis (HyperKPP) is characterized by myotonic discharges and weakness/paralysis. It is a channelopathy that is caused by mutation in the SCN4A gene that encodes for the skeletal muscle Na+ channel isoform (Nav1.4) α-subunit. Limb muscles are severely affected while breathing musculature is rarely affected even though diaphragm expresses the Nav1.4 channel. The objective of this study was to investigate the mechanism(s) that render the HyperKPP diaphragm asymptomatic in order to find a novel long lasting therapeutic approach, to treat HyperKPP symptoms. A HyperKPP mouse model carrying the M1592V mutation was used because it has a similar phenotype to that of patients carrying the same mutation. HyperKPP diaphragm, the limb muscles soleus and EDL all had a higher tetrodotoxin (TTX) sensitive Na+ influx than wild type (WT), but only the soleus and EDL had a depolarized resting potential, lower force and greater K+-induced force loss when compared to WT. The lack of a membrane depolarization in HyperKPP diaphragm was because of greater electrogenic contribution of the Na+ K+ ATPase pump compared to WT while such increase was not observed in EDL and soleus. HyperKPP diaphragm also had greater action potential amplitude than EDL and soleus possibly because of higher Na+ K+ ATPase pump maintaining a low [Na+]i. An inhibition of PKA, but not of PKC, increased the sensitivity of the HyperKPP diaphragm to the K+-induced force depression. So, HyperKPP soleus was exposed to forskolin to increase cAMP levels in order to activate PKA to document whether greater activity of PKA will alleviate HyperKPP symptoms. At 4.7 mM K+, forskolin increased force production, but worsened the decrease in force at 8 and 11 mM K+. Forskolin also did not improve membrane excitability. Pinacidil a KATP channel opener, improved force production at all [K+]e by causing a hyperpolarization of resting EM which then allowed for greater action potential amplitude and more excitable fibers. It is concluded that the development of a better therapeutic approach to treat HyperKPP can include a mechanism which activates Na+ K+ ATPase pumps and KATP channels.
56

Nouvelle synthèse de dérivés hétérocycliques thiazoliques, sélénazoliques, coumariniques, thiocoumariniques et quinolonéiques. Étude et évaluation de leur activité potentielle anticancéreuse / New synthesis of heterocyclic derivatives of thiazoles, selenazoles, coumarins, thiocoumarines, quinolones. Study and evaluation of their anticancer activity.

Xu, Zhanjie 23 May 2014 (has links)
Nous avons réalisé la synthèse de thiazoles, sélénazoles, thiéno[2,3-d]thiazoles et thiéno[2,3-d][1,3]sélénazoles, ce dernier étant préparé facilement à partir de cyanamide et de sulfure de carbone. Nous avons de cette manière pu synthétiser des 4-amino-1,3-thiazoles et 1,3-sélénazoles substitués en position 2 et 5 en deux étapes. Appliqué ces hétérocycles, les 4-halogéno-1,3-thiazoles et 1,3-sélénazoles ont été synthétisés par la méthode de Doyle. La labilité des halogènes dans les dérivés précédents a permis de préparer de nouveaux thiéno[2,3-d]thiazoles et [1,3]sélénazoles. La détermination du potentiel antiprolifératif de ces composés a permis de mettre en évidence deux composés, présentant des IC50 de l’ordre du micromolaire sur les lignées cellulaires cancéreuses : MCF-7, PC-3, Hs683, U373, SKMEL-28 et A549. Un composé surtout a montré une activité d’inhibition de Na+/K+-ATPase et de l'oncogène Ras. Par ailleurs dans un second sujet, nous nous sommes intéressés à la mise au point d’une synthèse des deux isomères (alpha et bêta) de 4-butoxylvinyl-coumarines, -thiocoumarine et -2-quinolones par couplage de Heck. Nous avons ainsi pu montrer que suivant le substituant présent en position 4 des hétérocycles le couplage était régiosélectif. Ces dérivés butoxyvinyliques se caractérisaient par leur caractère diénique et nous avons étudié leur réactivité, stéréoséléctivité et régiosélectivité avec différents diénophiles dans des réactions de cycloaddition de Diels-Alder. Parmi tous les composés polyhétérocycliques ainsi préparés, nous avons identifié des composés tétracycliques à noyau quinonique qui présentent un potentiel anticancéreux par des valeurs d’IC50 sur l’inhibition des phosphatases CDC25 et sur plusieurs lignées de cellules tumorales / We performed the synthesis of thiazoles, selenazoles, thieno[2,3-d]thiazoles and thieno[2,3-d][1,3] selenazoles which are easily prepared from cyanamide and carbon disulfide. By this way, we have synthesized 4-amino-1,3-thiazoles et 1,3-selenazoles substituted in position 2 and 5 in two steps. Used these heterocycles, 4-halogeno-1,3-thiazoles et 1,3-selenazoles were synthesized by Doyle’s method. Lability of halogens in previous derivatives allowed to prepare new thieno[2,3-d]thiazoles and [1,3]selenazoles. Determination of the antiproliferative activity of these compounds has brought out two compounds, showing IC50 values in micromolar range on investigated cancer cell lines: MCF-7, PC-3, Hs683, U373, SKMEL-28, and A549. One particular compound showed a high activity of anti-Na+/K+-ATPase and anti-ROS. In addition in the second subject, we were interested in the development of the synthesis of two isomers (alpha and beta) of 4-butoxylvinyl-coumarins, -thiocoumarin and -2-quinolones by Heck coupling. We showed that, depending on the substituent in the position 4 of the heterocycle, the coupling was regioselective. These butoxyvinylic derivatives, characterized by dienic character, were studied for their reactivity, stereoselectivity and regioselectivity with several dienophiles in Diels-Alder cycloaddition. Among all the polyheterocyclic compounds prepared, we have identified the tetracyclic compounds with quinonic ring which have potential anticancer activity by inhibition of CDC25 phosphatase and on several tumor cell lines
57

Wortmannin Inhibition of Forskolin-Stimulated Chloride Secretion by T84 Cells

Ecay, Tom W., Dickson, Jeffrey L., Conner, Tracy D. 31 July 2000 (has links)
The time- and dose-dependent effects of wortmannin on transepithelial electrical resistance (R(te)) and forskolin-stimulated chloride secretion in T84 monolayer cultures were studied. In both instances, maximal effects developed over 2 h and were stable thereafter. Inhibition of forskolin-stimulated chloride secretion, as measured by the short-circuit current (I(SC)) technique, had an IC50 of 200-500 nM, which is 100-fold higher than for inhibition of phosphatidylinositol 3-kinase (PI3K), but similar to the IC50 for inhibition of myosin light chain kinase (MLCK) and mitogen-activated protein kinases (MAPK). Previous work demonstrated that 500 nM wortmannin did not inhibit the cAMP activation of apical membrane chloride channels. We show here that 500 nM wortmannin has no affect on basolateral Na/K/2Cl-cotransporter activity, but inhibits basolateral membrane Na/K-ATPase activity significantly. The MLCK inhibitors ML-7 and KT5926 were without affect on forskolin-stimulated I(SC). Similarly, the p38- and MEK-specific MAPK inhibitors SB203580 and PD98059 did not reduce forskolin-stimulated I(SC). In contrast, the non-specific MAPK inhibitor apigenin reduced forskolin-stimulated I(SC) and basolateral membrane Na/K-ATPase activity similar to wortmannin. In isolated membranes from T84 cells, wortmannin did not inhibit Na/K-ATPase enzymatic activity directly. We conclude that one or more MAPK may regulate the functional expression of basolateral membrane Na/K-ATPase by controlling the abundance of enzyme molecules in the plasma membrane.
58

Sodium Pumps Keep Us Running: Distinct Roles For Na,K-ATPase Isozymes In Regulation of Skeletal Muscle Excitability

Hakimjavadi, Hesamedin 10 June 2019 (has links)
No description available.
59

GRP78/BiP is Involved in Ouabain-induced Endocytosis of the Na/K-ATPase in LLC-PK1 Cells

Kesiry, Riad 27 September 2004 (has links)
No description available.
60

Regulation of IP3 Receptor-Mediated Calcium Release by Na/K-ATPase

Chen, Ying January 2007 (has links)
No description available.

Page generated in 0.141 seconds